In November, Geoff Banda, Innogen Deputy Director, attended the launch of The Health Research and Innovation Strategy for Africa 2018-2030, developed by the African Union Development Agency (AUDA)-NEPAD, and spoke at the 2nd Vaccine Manufacturing Forum.
The Health Research and Innovation Strategy for Africa 2018-2030 (HRISA) was launched in Nairobi, Kenya, on the 26th November. Since 2017 Geoff has been a member of the Technical Working Group for AUDA-NEPAD that drafted the document and has participated in subsequent validation workshops. The launch of the strategy took place during a 3-day priority-setting workshop, in which representatives from over 40 African Regional Economic Communities (REC), other organisations and researchers discussed the design of a monitoring and evaluation framework for the strategy.
Earlier in the month, Geoff spoke at the 2nd Vaccine Manufacturing Forum in Casablanca, Morocco, about innovative funding models for local and sustainable vaccine manufacture. This meeting brought together over 90 people from across the whole continent interested in accelerating local vaccine manufacture in Africa and local health security.
“It has been an honour to work and collaborate with colleagues from AUDA/NEPAD, EDCTP, PATH, IAVI, South African MRC, SanBio, TIBA Kenya and Zimbabwe, University of Zambia, WHO-Afro, Africa-CDC, African Union, and representatives from African RECs, amongst others, in the various meetings that resulted in the HRISA document,” says Geoff Banda, Deputy Director of Innogen.